Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/5/2010

neral and administrative costs from lower clinical and regulatory-related costs, combined with lower stock-based compensation charges.  Partially offsetting these decreases was an increase in sales and marketing expenses during the 2010 period as a result of the development of our commercial infrastructure during the previous several quarters in preparation for the commercial launch of OFIRMEV.

Operating expenses for the nine months ended September 30, 2010 increased $7.3 million to $36.7 million, from the $29.4 million reported for the same period in 2009. This increase was primarily due to a significant increase in the company's sales and marketing expenses as a result of preparations for the commercial launch of OFIRMEV, including developing a commercial infrastructure and the addition of headcount to support the launch. Cadence also incurred a charge of $1.5 million during the nine months ended September 30, 2010 related to the partial cancellation of a capital equipment order.  Partially offsetting these increases, was a decrease in the company's research and development expenses, primarily due to the discontinuation of the company's omiganan pentahydrochloride product candidate in March 2009 and the completion of its clinical development program for OFIRMEV in May 2009.

As of September 30, 2010, Cadence held cash, cash equivalents and short-term investments of $59.7 million.  

Conference Call and Webcast on November 5, 2010 at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time)Cadence management will host a conference call on November 5, 2010 at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time) and interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international). To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page. A replay of the webcast will be
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
11. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 4, 2015 A ... of hypertension, diabetes and thyroid disorders in Central and ... educational platforms and a major conference dedicated to these ... Manage Diabetes Online , Manage Hypertension Online ... developed and operated by EXCEMED - combine ...
(Date:7/3/2015)... 3, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... éducatives gratuites et d,une conférence majeure dédiée à ... ) , Les formations ... Prendre en charge l,hypertension en ligne ...
(Date:7/3/2015)... MUMBAI , July 3, 2015 /PRNewswire/ ... gab heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine ... Russland erworben zu haben. Mit dieser Übernahme ... der mit einem Umsatz von 765 Mrd. ... größten Pharmamärkten der Welt gehörte (IMS Health). ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3
... 2a Clinical Trial at UCSD, NOVATO, ... or the "Company") (OTC Bulletin Board:,RPTP), today ... (the,"Agreement") with the University of California, San ... trial to evaluate a delayed-release preparation,of cysteamine ...
... Corporation, a,Georgia-based biotech company, announced today a ... collaboration with Cato Research Ltd.,its global contract ... will help support continued development of Abeome,s ... vastly improves the development of,monoclonal antibodies and ...
Cached Medicine Technology:Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2
(Date:7/6/2015)... ... , ... “ TapGlance ” was featured on NewsWatch as part of its ... market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology ... helps users visualize what rooms will look like before they even start renovating.. , ...
(Date:7/6/2015)... ... , ... June 22, 2015, Fox News in a report titled “ Female Hair Loss Needs to ... a quarter of all women in the U.S. will suffer from thinning hair or hair ... discussed. One woman, a former beauty queen, who was interviewed for the report began losing ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... care from nurses or midwives, yet there is a large gap between the ... midwifery research required to improve health outcomes and reduce unnecessary or ineffective treatments ...
(Date:7/6/2015)... ... ... Olive Fertility Centre is proud to announce that Olive medical director Dr. ... the department of Family Practice. , “This award is a real honour,” says Dr ... is changing so rapidly and we are also developing new models of patient-centred care ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, the highest ... with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ultrasound screenings ... Screenings are affordable and accurate and run about an hour long with same ...
Breaking Medicine News(10 mins):Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2
... ... of postmortem procedures , ... AZ (Vocus) February 4, 2010 -- Doctors or pathology technicians perform autopsies to diagnose any ... to the decedent’s death. The postmortem examination is of great importance to the family of ...
... ... risks associated with use of popular GlaxoSmithKline diabetes drug , ... Mineola, NY (Lexis Nexis) February 4, 2010 ... of opinions concerning the safety of its much touted diabetes drug Avandia , ...
... This ... expertise in the field of Lower Gastrointestinal, Urological and Sexual Dysfunction disorders. , ... (PRWEB) February 4, 2010 -- In an ... field of Lower Gastrointestinal, Urological and Sexual Dysfunction disorders with colleagues and patients around the ...
... (February 4, 2010) In a study to be presented today ... Meeting , in Chicago, researchers will unveil findings that detail an ... near-term scheduled births that did not have an appropriate medical ... by induction of labor, has been on the rise in recent ...
... COPD MAY BE OVERSTATED , Inhaled ... obstructive pulmonary disease (COPD). However, new research suggests that ICS ... patients with COPD. Researchers from India conducted a metaanalysis of ... versus placebo in prevention of COPD exacerbations. The use of ...
... CHICAGO, Ill. (February 4, 2010) In a study to ... annual meeting, The Pregnancy Meeting , in Chicago, researchers will ... treatment for depression during pregnancy. "Depression during pregnancy is ... both the mother and the baby as well as the ...
Cached Medicine News:Health News:Author Presents a Practical Guide for Postmortem Examinations 2Health News:New Scientific Studies Show Further Evidence of Avandia Dangers 2Health News:New Scientific Studies Show Further Evidence of Avandia Dangers 3Health News:International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine 2Health News:International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine 3Health News:Report documents statewide initiative to reduce near-term scheduled births 2Health News:News briefs from the February issue of Chest 2Health News:Acupuncture found effective against depression during pregnancy 2
Microseal 'F' foil, seals plates for cold storage (or cycling >25l), disposable, pkg of 100...
... Applied Biosystems has developed a comprehensive ... when using sequence detection systems (SDS) ... simple and easy to follow. Many ... concentration and the thermal cycling protocol ...
Microporous tape sheets for covering 96-well plates, square-well or flat-bottom blocks.;...
ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
Medicine Products: